These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 32510928)
21. Altering the viscoelastic properties of mucus-grown Rouillard KR; Markovetz MR; Kissner WJ; Boone WL; Plott LM; Hill DB Biofilm; 2023 Dec; 5():100104. PubMed ID: 36711323 [TBL] [Abstract][Full Text] [Related]
22. Activity of Antibiotics against Pseudomonas aeruginosa in an Diaz Iglesias Y; Van Bambeke F Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015047 [No Abstract] [Full Text] [Related]
23. Pseudomonas aeruginosa Increases the Sensitivity of Biofilm-Grown Staphylococcus aureus to Membrane-Targeting Antiseptics and Antibiotics. Orazi G; Ruoff KL; O'Toole GA mBio; 2019 Jul; 10(4):. PubMed ID: 31363032 [No Abstract] [Full Text] [Related]
24. Effect of pH on the antimicrobial susceptibility of planktonic and biofilm-grown clinical Pseudomonas aeruginosa isolates. Moriarty TF; Elborn JS; Tunney MM Br J Biomed Sci; 2007; 64(3):101-4. PubMed ID: 17910277 [TBL] [Abstract][Full Text] [Related]
25. Extracellular DNA release, quorum sensing, and PrrF1/F2 small RNAs are key players in Tahrioui A; Duchesne R; Bouffartigues E; Rodrigues S; Maillot O; Tortuel D; Hardouin J; Taupin L; Groleau MC; Dufour A; Déziel E; Brenner-Weiss G; Feuilloley M; Orange N; Lesouhaitier O; Cornelis P; Chevalier S NPJ Biofilms Microbiomes; 2019; 5(1):15. PubMed ID: 31149345 [TBL] [Abstract][Full Text] [Related]
26. Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms. Díez-Aguilar M; Morosini MI; Köksal E; Oliver A; Ekkelenkamp M; Cantón R Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084746 [No Abstract] [Full Text] [Related]
27. In vitro approach to study the synergistic effects of tobramycin and clarithromycin against Pseudomonas aeruginosa biofilms using prokaryotic or eukaryotic culture media. Thellin O; Zorzi W; Jolois O; Elmoualij B; Duysens G; Cahay B; Streel B; Charif M; Bastin R; Heinen E; Quatresooz P Int J Antimicrob Agents; 2015 Jul; 46(1):33-8. PubMed ID: 25963337 [TBL] [Abstract][Full Text] [Related]
28. Nitric oxide-releasing polyacrylonitrile disperses biofilms formed by wound-relevant pathogenic bacteria. Craven M; Kasper SH; Canfield MJ; Diaz-Morales RR; Hrabie JA; Cady NC; Strickland AD J Appl Microbiol; 2016 Apr; 120(4):1085-99. PubMed ID: 26784529 [TBL] [Abstract][Full Text] [Related]
29. Optimization of colistin dosing regimen for cystic fibrosis patients with chronic Pseudomonas aeruginosa biofilm lung infections. Hengzhuang W; Green K; Pressler T; Skov M; Katzenstein TL; Wu X; Høiby N Pediatr Pulmonol; 2019 May; 54(5):575-580. PubMed ID: 30803159 [TBL] [Abstract][Full Text] [Related]
30. Optimization of nitric oxide donors for investigating biofilm dispersal response in Pseudomonas aeruginosa clinical isolates. Cai YM; Webb JS Appl Microbiol Biotechnol; 2020 Oct; 104(20):8859-8869. PubMed ID: 32865612 [TBL] [Abstract][Full Text] [Related]
33. Antibiotics Enhance Prevention and Eradication Efficacy of Cathodic-Voltage-Controlled Electrical Stimulation against Titanium-Associated Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa Biofilms. Canty MK; Hansen LA; Tobias M; Spencer S; Henry T; Luke-Marshall NR; Campagnari AA; Ehrensberger MT mSphere; 2019 May; 4(3):. PubMed ID: 31043516 [TBL] [Abstract][Full Text] [Related]
34. Discovery of Cephalosporin-3'-Diazeniumdiolates That Show Dual Antibacterial and Antibiofilm Effects against Rineh A; Soren O; McEwan T; Ravikumar V; Poh WH; Azamifar F; Naimi-Jamal MR; Cheung CY; Elliott AG; Zuegg J; Blaskovich MAT; Cooper MA; Dolange V; Christodoulides M; Cook GM; Rice SA; Faust SN; Webb JS; Kelso MJ ACS Infect Dis; 2020 Jun; 6(6):1460-1479. PubMed ID: 32329596 [TBL] [Abstract][Full Text] [Related]
35. In Vivo Efficacy of Antimicrobials against Biofilm-Producing Pseudomonas aeruginosa. Pawar V; Komor U; Kasnitz N; Bielecki P; Pils MC; Gocht B; Moter A; Rohde M; Weiss S; Häussler S Antimicrob Agents Chemother; 2015 Aug; 59(8):4974-81. PubMed ID: 26055372 [TBL] [Abstract][Full Text] [Related]
36. Sequential Treatment of Biofilms with Aztreonam and Tobramycin Is a Novel Strategy for Combating Pseudomonas aeruginosa Chronic Respiratory Infections. Rojo-Molinero E; Macià MD; Rubio R; Moyà B; Cabot G; López-Causapé C; Pérez JL; Cantón R; Oliver A Antimicrob Agents Chemother; 2016 May; 60(5):2912-22. PubMed ID: 26926631 [TBL] [Abstract][Full Text] [Related]
37. Effect of oxygen limitation on the in vitro antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa grown planktonically and as biofilms. Field TR; White A; Elborn JS; Tunney MM Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):677-87. PubMed ID: 16249934 [TBL] [Abstract][Full Text] [Related]
38. An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections. Koeva M; Gutu AD; Hebert W; Wager JD; Yonker LM; O'Toole GA; Ausubel FM; Moskowitz SM; Joseph-McCarthy D Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923873 [TBL] [Abstract][Full Text] [Related]